top of page

Chemical Biology Ventures Limited (CBV) provides world-class life & chemical science R&D consultancy, business & educational services to the international pharmaceutical, biotech, investment, academic & educational sectors

 

Focussed at the intersection between chemistry & biology, Chemical Biology Ventures aims to maximise project progress, outcomes & return on investment for all stakeholders.

 

Please browse through this website to get a sense of the breadth of CBV's experience & expertise.

 

Contact CBV to explore how we could work with you.

News

Why Choose CBV?

  • Facebook
  • Twitter
  • LinkedIn

CBV founder, Lloyd Czaplewski PhD FRSC, has over 30-years of chemical biology experience across multiple therapeutic areas and from concept to clinic.

 

"I'm passionate about translating world-class science into real benefits for society & the creation of wealth"

CBV Blog

A discussion on antibacterial R&D, funding, ideas for areas that could be investigated, comments on papers etc ..... please feel free to join in and agree or disagree!

Tel: +44 (0) 1235 532481  Mob: 07836 554231 Email: email@chembioventures.com

Chemical Biology Ventures Limited. Registered in England & Wales number 7968150. Registered office: 30 Upper High Street, Thame, Oxfordshire, OX9 3EZ. Address for correspondence: 123 Alexander Close, Abingdon, Oxfordshire, OX14 1XD

bhZpDiE_YVvN2fZj50TWwV3FWhQ

© Copyright 2012 Chemical Biology Ventures Limited. All Rights Reserved. Registered in England & Wales number 7968150. Registered office: 30 Upper High Street, Thame, Oxfordshire, OX9 3EZ. Address for correspondence: 123 Alexander Close, Abingdon, Oxfordshire, OX14 1XD

Services

Welcome

Creating & Translating

CBV can help create biological and chemical intellectual property & has experience in discovery & patent busting approaches to establish, exemplify & protect research portfolios.

 

There are many paths from patent to product & CBV can help you decide & deliver the right one for you.

 

Chemical biology is driving the next phase of the biomedical & industrial biotechnology revolution leading to new product opportunities.

 

When the basic research is complete & the translational research or preclinical R&D starts a whole new set of skills & processes are required to transform research projects into products.

 

Based on experiences in project & Company growth, fund-raising, business development & Company sale to provide an exit for investors CBV can provide support or hands-on resource to accelerate research & commercialisation.

Translating Science into Health

CBVlogo4
bottom of page